A systematic review and meta-analysis of interventional studies of bisphosphonates and denosumab in multiple myeloma and future perspectives

Bisphosphonates (BPs) and denosumab (DENOS), due to their ability to inhibit osteoclast activity, are used to prevent skeletal complications in multiple myeloma (MM) patients. The NCBI PubMed, Web of Science, Scopus and ClinicalTrials.gov databases, were systematically searched for interventional st...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatziravdeli, Vasiliki, Katsaras, Georgios N., Katsaras, Dimitrios, Doxani, Chrysoula, Stefanidis, Ioannis, Zintzaras, Elias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Musculoskeletal and Neuronal Interactions 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716295/
https://www.ncbi.nlm.nih.gov/pubmed/36458395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716295/
https://www.ncbi.nlm.nih.gov/pubmed/36458395

Ejemplares similares